The Austrian authorities decided to suspend the use of a batch of vaccine developed by the British-Swedish company AstraZeneca after the death of one vaccinated woman and complications in another. This was reported by the Federal Office for Health Security (BASG).
According to a press release, a 49-year-old woman who received a coronavirus vaccine died as a result of severe bleeding disorders. Another vaccinated woman, aged 35, developed pulmonary embolism.
As specified, both women received the vaccine from the same batch of AstraZeneca.
“There is no evidence of a causal relationship with vaccination,” the ministry said in a statement.
An investigation is currently underway to rule out a link between the deterioration of the health status of the vaccinated and vaccination.
Previously, Canada’s National Advisory Committee on Immunization recommended that AstraZeneca vaccine not be used by people 65 years of age or older.